Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03786952 · ClinicalTrials.gov registry record · NA
Stress, Sex, and the Generalization of Fear
A NA study of Psychological Stress, sponsored by Ohio Northern University.
- Completed
- Registry status
- NA
- Development phase
- 606
- Enrollment target
- 1
- Study location
NCT03786952: Completed NA study of Psychological Stress, sponsored by Ohio Northern University.
NCT03786952 is a NA study of Psychological Stress that has completed, run by Ohio Northern University. The registered enrollment target is 606 participants, above the 314-participant average among 13 other Psychological Stress trials with a reported enrollment target (93% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03786952, a NA study of Psychological Stress, has completed, sponsored by Ohio Northern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 606 participants
- Enrollment target
- 1
- Study location
Study Summary
The impact of well-known risk factors for such disorders (stress, biological sex, anxiety-related dispositions) on fear generalization will be examined. Findings from this study may provide insight into how these risk factors influence the development and/or maintenance of psychological disorders that involve overgeneralization of fear and could facilitate future approaches to their treatment.
Primary Outcome
Peak eyeblink startle responses 20-200 ms following presentation of a startle probe were measured. Startle responses were assessed for each of 3 trial types: (1) following the startle probe alone \[noise alone (NA) trials\], (2) following the CS+ and startle probe (CS+ trials), and (3) following the CS- and startle probe (CS- trials). Participants were exposed to 16 blocks of trials, and each block included 1 presentation of each trial type. During the last 12 blocks, CS+ trials also included th
Conditions Studied
Interventions
- BEHAVIORAL Stress immediately before learning in males
- BEHAVIORAL Sham control immediately before learning in males
- BEHAVIORAL Stress 30 minutes before learning in males
- BEHAVIORAL Sham control 30 minutes before learning in males
- BEHAVIORAL Stress immediately before learning in females
Study Locations (1)
Ohio
- Ohio Northern University - Ada
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 606 participants |
| Start Date | 2019-01-25 |
| Est. Completion | 2022-06-30 |
| Phase | NA |
What the finished NCT03786952 record still lists
NCT03786952 is an interventional study that assigns participants to a tested intervention. The registered 606 participants enrollment target is mid-sized for trials with a published cap, above the 314-participant average among 13 other Psychological Stress trials with a reported enrollment target (93% higher).
The record links to 1 condition, with Psychological Stress appearing as the primary indexed condition, and to 5 interventions - of which Stress immediately before learning in males is the first listed.
NCT03786952 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03786952 about?
NCT03786952 is a clinical study titled "Stress, Sex, and the Generalization of Fear". The impact of well-known risk factors for such disorders (stress, biological sex, anxiety-related dispositions) on fear generalization will be examined. Findings from this study may provide insight into how these risk factors influence the development and/or maintenance of psychological disorders th...
What is the current status of trial NCT03786952?
This trial is currently completed. It is a NA study. The enrollment target is 606 participants. The study started on 2019-01-25. Estimated completion is 2022-06-30.
What conditions does trial NCT03786952 study?
This clinical trial studies the following conditions: Psychological Stress.
What interventions are being tested in trial NCT03786952?
The interventions under investigation include: Stress immediately before learning in males (BEHAVIORAL), Sham control immediately before learning in males (BEHAVIORAL), Stress 30 minutes before learning in males (BEHAVIORAL), Sham control 30 minutes before learning in males (BEHAVIORAL), Stress immediately before learning in females (BEHAVIORAL).
Who is sponsoring clinical trial NCT03786952?
This trial is sponsored by Ohio Northern University, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03786952 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Psychological Stress
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03786952's enrollment target sits among peer trials
606 3rd of 13 higher than 11 of 13 other Psychological Stress trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Psychological Stress trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cerebrovascular Health and Resilience in Midlife
RECRUITING · NA
-
Trauma and Cardiometabolic Health in an American Indian Community
RECRUITING · NA
-
Strategies for Pregnancy Achievement
ACTIVE NOT RECRUITING · NA
-
Psychological and Physiological Effects of Different Objects of Breath Meditation
COMPLETED · NA
-
Effects of an Intervention to Enhance Resilience in Physical Therapy Students
COMPLETED · NA
-
Stress Management Training for Healthy Aging
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02342444 · 606 participants · Phase 4
Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)
- NCT02064673 · 608 participants · Phase 3
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy
- NCT06091202 · 608 participants · Phase 3
Tele-Collaborative Outreach to Rural Patients With Chronic Pain
- NCT06098144 · 608 participants · Phase 4
Smoking Cessation Program in the Construction Sector
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI